Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.51 USD | +2.50% | +0.89% | +40.43% |
20/03 | Canaccord Genuity Adjusts Price Target on Tenaya Therapeutics to $18 From $19, Maintains Buy Rating | MT |
19/03 | North American Morning Briefing : Stock Futures -2- | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+40.43% | 35Cr | |
+26.50% | 4.92TCr | |
+0.57% | 4.21TCr | |
+50.47% | 4.04TCr | |
-5.26% | 2.89TCr | |
+13.58% | 2.61TCr | |
-22.38% | 1.87TCr | |
+7.92% | 1.33TCr | |
+31.90% | 1.23TCr | |
+0.13% | 1.2TCr |
- Stock Market
- Equities
- TNYA Stock
- News Tenaya Therapeutics, Inc.
- Tenaya Therapeutics Says US FDA Grants Fast Track Label for Heart Disease Drug Candidate